We are monitoring the impact of COVID-19 on Europe Clinical Nutrition Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 729
Share on
Share on

Europe Clinical Nutrition Market Research Report - By Product Type, Therapeutic Areas, Ingredients Type and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 729
Pages: 143

Europe Clinical Nutrition Market Size (2021 to 2026)

The size of the Clinical Nutrition market in Europe was worth USD 3.82 Billion in 2021 and is estimated to be growing at a CAGR of 7.17% and worth USD 5.39 Billion by 2026. The European clinical nutrition market is driven by the aging population and increased disease diagnosis.

The rising prevalence of metabolic disorders and excessive healthcare spending are two important drivers driving the European clinical nutrition market expansion. Over the last decade, the number of people diagnosed with metabolic diseases has increased, increasing the number of individuals diagnosed.

Dietary therapy is necessary for normal growth and development and to prevent acute and long-term effects of the disorder. In people with metabolic diseases, failing to follow a certain nutritional regimen can lead to problems and even death. Nutritional therapy is required for patients with hereditary metabolic abnormalities for the rest of their lives. Treating patients with various inborn metabolic necessitates a multidisciplinary strategy that includes both dietary and medical care.

The inability of the body to create non-essential molecules such as vitamins, amino acids, and several chemicals involved in metabolic pathways causes the majority of metabolic disorders. Most of these ailments can be treated with just one or two vitamin pills. All of these factors have a role in the market’s expansion.

The European clinical nutrition market is being held back by the necessity to meet nutritional therapy's safety and quality criteria. Pharmaceutical items include clinical nutritional supplements. The producers should adhere to Food and Drug Administration and European Medicines Agency’s recommendations. The challenges in obtaining permissions from government bodies are a significant challenge.

Impact of COVID-19 on the European Clinical Nutrition Market:

Infection with COVID-19 has become a serious public health concern, and clinical nutrition can help prevent infection and treat infection-related malnutrition. The European Society for Clinical Nutrition and Metabolism, for example, has published nutritional therapy guidelines for COVID-19 infected ICU patients. As a result, nutritional support plays a critical role in this context, assisting the segment’s growth.

This research report on the European clinical nutrition market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Oral Nutrition
  • Enteral Nutrition
  • Parenteral Nutrition

By Therapeutic Areas: 

  • Malabsorption
  • Diarrhea
  • Cancer
  • Food Allergies
  • Maldigestion
  • Diabetes
  • Short-Bowel Syndrome
  • Acute Lung Injury
  • Acute Respiratory Distress

By Ingredients Type: 

  • Vitamins
  • Minerals
  • Carbohydrates
  • Amino Acids

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

The Europe Clinical Nutrition Market is estimated to develop at a healthy growth rate over the forecast period. Excessive healthcare spending and the increased prevalence of metabolic illnesses are two major factors driving the market growth.

The German clinical nutrition market is expected to showcase a significant CAGR during the forecast period, from the large number of people suffering from chronic diseases, an aging population, and an increase in the incidence of metabolic disorders. The country also has a high prevalence of metabolic syndrome, characterized by anomalies such as hypertension, abdominal obesity, dyslipidemia, and raised blood glucose levels.

As individuals age older in Germany, the number of multimorbid patients is also rising. According to a survey conducted by Germany Health Update, the overall prevalence of multimorbid individuals is roughly 39%.

According to the Global Health and Wellness Survey, more than 70% of Germans aged 65 and over had a metabolic condition in the previous year. Furthermore, food therapy is an important aspect of treating many illnesses to minimize acute repercussions, such as metabolic decompensation and long-term complications.

The UK clinical nutrition market is another lucrative regional market in Europe to capture the growth possibilities for the market participants during the forecast period. In addition, countries such as France, Spain, and Italy are expected to have promising growth rates during the forecast period.

KEY MARKET PLAYERS:

Notable companies operating in the Europe Clinical Nutrition Market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By Route of Administration               

                             5.1.1 Oral Nutrition       

                             5.1.2 Enteral Nutrition  

                             5.1.3 Parenteral Nutrition          

              5.2 By Therapeutic Area                            

                             5.2.1 Malabsorption     

                             5.2.2 Diarrhoea

                             5.2.3 Cancer     

                             5.2.4 Food Allergies       

                             5.2.5 Maldigestion         

                             5.2.6 Diabetes  

                             5.2.7 Short-Bowel Syndrome     

                             5.2.8 Acute Lung Injury

                             5.2.9 Acute Respiratory Distress             

              5.3 By Ingredients Type              

                             5.3.1 Vitamins  

                             5.3.2 Minerals  

                             5.3.3 Carbohydrates     

                             5.3.4 Amino Acids          

6. Geographical Analysis                                         

                             6.1 Introduction             

                             6.2 U.K 

                             6.3 Spain           

                             6.4 Germany    

                             6.5 Italy             

                             6.6 France         

7. Strategic Analysis                                   

              7.1 PESTLE analysis                      

                             7.1.1 Political    

                             7.1.2 Economic

                             7.1.3 Social       

                             7.1.4 Technological       

                             7.1.5 Legal         

                             7.1.6 Environmental     

              7.2 Porter’s Five analysis                          

                             7.2.1 Bargaining Power of Suppliers       

                             7.2.2 Bargaining Power of Consumers   

                             7.2.3 Threat of New Entrants    

                             7.2.4 Threat of Substitute Products and Services             

                             7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                    

              8.1 Nestle Nutrition                     

                             8.1.1 Overview 

                             8.1.2 Product Analysis  

                             8.1.3 Strategic Evaluation and Operations          

                             8.1.4 Financial analysis 

                             8.1.5 Legal issues           

                             8.1.6 Recent Developments       

                             8.1.7 SWOT analysis      

                             8.1.8 Analyst View         

              8.2 Abbott Laboratories Inc.                    

              8.3 Gentiva Health Services Inc.              

              8.4 Mead Johnson & Company               

              8.5 Kendall                      

              8.6 Ajinomoto Co. Inc.                

              8.7 Hospira Inc.              

              8.8 Hero Nutritionals Inc.                         

              8.9 Lonza Ltd                  

              8.10 Baxter International Inc.                  

              8.11 B. Braun Melsungen AG                   

              8.12 H. J. Heinz Company                         

9. Competitive Landscape                                       

              9.1 Market share analysis                         

              9.2 Merger and Acquisition Analysis                    

              9.3 Agreements, collaborations and Joint Ventures                      

              9.4 New Product Launches                       

10. Expert Opinions                                   

              10.1 Market Outlook                   

              10.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Clinical Nutrition Market, By Region, From 2021 to 2026 (USD Billion)
  2. Europe Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  3. Europe Oral Nutrition Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Enteral Nutrition Market, By Region, From 2021 to 2026 (USD Billion)
  5. Europe Parenteral Nutrition Market, By Region, From 2021 to 2026 (USD Billion)
  6. Europe Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  7. Europe Malabsorption Market, By Region, From 2021 to 2026 (USD Billion)
  8. Europe Diarrhea Market, By Region, From 2021 to 2026 (USD Billion)
  9. Europe Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  10. Europe Food Allergies Market, By Region, From 2021 to 2026 (USD Billion)
  11. Europe Maldigestion Market, By Region, From 2021 to 2026 (USD Billion)
  12. Europe Diabetes Market, By Region, From 2021 to 2026 (USD Billion)
  13. Europe Short-Bowel Syndrome Market, By Region, From 2021 to 2026 (USD Billion)
  14. Europe Acute Lung Injury Market, By Region, From 2021 to 2026 (USD Billion)
  15. Europe Acute Respiratory Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  16. Europe Clinical Nutrition Market, By Ingredients Type, From 2021 to 2026 (USD Billion)
  17. Europe Vitamins Market, By Region, From 2021 to 2026 (USD Billion)
  18. Europe Minerals Market, By Region, From 2021 to 2026 (USD Billion)
  19. Europe Carbohydrates Market, By Region, From 2021 to 2026 (USD Billion)
  20. Europe Amino Acids Market, By Region, From 2021 to 2026 (USD Billion)
  21. U.K Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  22. U.K Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  23. U.K Clinical Nutrition Market, By Ingredients Type, From 2021 to 2026 (USD Billion)
  24. Spain Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  25. Spain Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  26. Spain Clinical Nutrition Market, By Ingredients Type, From 2021 to 2026 (USD Billion)
  27. Germany Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  28. Germany Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  29. Germany Clinical Nutrition Market, By Ingredients Type, From 2021 to 2026 (USD Billion)
  30. Italy Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  31. Italy Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  32. Italy Clinical Nutrition Market, By Ingredients Type, From 2021 to 2026 (USD Billion)
  33. France Clinical Nutrition Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  34. France Clinical Nutrition Market, By Therapeutic Area, From 2021 to 2026 (USD Billion)
  35. France Clinical Nutrition Market, By Ingredients Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample